The agreement with AstraZeneca expands on the strategic partnership between the two companies announced in 2021 and aims to leverage Tempus’ AI-enabled platform and vast repository of multimodal ...

strategic collaborations with AstraZeneca (LSE/STO/Nasdaq: AZN) and Pathos AI, Inc., in which the companies will work together to build a multimodal foundation model in oncology which can be used ...

AstraZeneca and Daiichi Sankyo have revealed that their new drug has shown a ‘meaningful improvement’ in survivability rates in patients suffering from an aggressive form of breast cancer ...

Former President Rodrigo Duterte is detained in the Hague by the International Criminal Court. File In the often fiery world of Philippine politics, few names ignite as much passion and division ...

If the tariff-loving leader goes ahead with his plans, it will hit AstraZeneca – the most valuable company on the UK stock market. It will also affect rival GSK, another stalwart of the FTSE 100.

She also expressed support for accusations of Israel committing genocide in the case that was prosecuted in the International Court of Justice in The Hague. Nixon has been ribbed online for her ...

in The Hague has agreed to postpone proceedings in the case brought by South Africa against Israel, following Israeli objections regarding procedural violations and a lack of transparency.

April 16 (Reuters) - AstraZeneca's (AZN.L), opens new tab Alexion Pharmaceuticals was sued in Massachusetts federal court on Wednesday in a class action complaint alleging it misused its patents ...

displaying messages such as “War criminals are not welcome here” and “First stop Harvard next stop The Hague.” Though two Harvard University Police Department officers were present at the ...

In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against other best pharma stocks to buy for long term growth. With big American pharmaceutical ...

AstraZeneca has a 52-week low of GBX 9,573.51 ($126.23) and a 52-week high of £133.88 ($176.53). The stock’s 50-day simple moving average is £114.28 and its 200 day simple moving average is £ ...